In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heidelberg Pharma Research GmbH

Division of Heidelberg Pharma AG
www.heidelberg-pharma.com

Latest From Heidelberg Pharma Research GmbH

Merck Serono enters antibody drug conjugate fray

Merck Serono has expanded its oncology activities into antibody drug conjugates (ADCs) through a deal signed with Cambridge, Massachusetts-based Mersana Therapeutics.

Cancer Companies

Takeda strengthens cancer focus with Mersana ADC deal

Takeda is ramping up its presence in oncology, having signed a deal with antibody-drug conjugate (ADC) specialist Mersana Therapeutics via subsidiary Millennium Pharmaceuticals.

Infectious Diseases Cancer

Wilex reduced to contract research as Rencarex fails to inspire any interest

Wilex is reducing its employees by 80% and focusing its business on contract research and the ADC technology at its subsidiary Heidelberg Pharma following a failure "to obtain project funding and licensing partnerships," it said.

Cancer Companies

Roche fronts $61m in DARPin deal with Molecular Partners

Roche has agreed to pay CHF55m ($61m) in up-front and initiation payments to Molecular Partners in a deal which will see the latter's novel class of small proteins – known as DARPins – conjugated to Roche drugs to treat cancer.

Cancer Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
      • Molecular Diversity
        • Natural Products
    • Large Molecule
      • Antibodies
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Heidelberg Pharma GMBH
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Heidelberg Pharma AG
  • Senior Management
  • Contact Info
  • Heidelberg Pharma Research GmbH
    Phone: (49) 6203 1009 0
    Schriesheimer Str. 101
    Ladenburg, 68526
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register